Sanofi-Aventis And Nichi-Iko Announce JV For Generics In Japan
This article was originally published in PharmAsia News
Executive Summary
Toyama-based Japanese generics drug maker Nichi-Iko announced May 28 that Sanofi-Aventis will invest $48 million in the company to jumpstart its generics business in Japan